Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Trandate

Trandate
In stock
50mg · 200mg · 100mg
from A$65.30
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$78.37A$65.30
A$2.18 per tablet

In brief

  • In our pharmacy, you can buy trandate without a prescription, with delivery across Australia; discreet packaging and anonymous delivery options available (note: officially trandate/labetalol is prescription-only in most countries).
  • Trandate (labetalol) is used to treat high blood pressure, including acute hypertensive crises and pregnancy-related hypertension; it is a non‑selective beta‑blocker with additional alpha‑1 blocking activity that reduces heart rate, cardiac output and peripheral vascular resistance.
  • The usual oral dose for adults starts at 100 mg twice daily; maintenance is commonly 200–400 mg twice daily, with divided doses up to 2,400 mg/day. For hypertensive emergencies IV boluses often start at 20 mg slow IV, or an infusion at 0.5–2 mg/min as guided by a clinician.
  • Available as oral tablets (commonly 100 mg, 200 mg, 300 mg and in some regions 400 mg) and as an intravenous solution for bolus or infusion (eg 5 mg/mL, 100 mg/20 mL vials).
  • Oral trandate usually begins to lower blood pressure within about 20–30 minutes (peak effect 1–2 hours); IV doses act within minutes.
  • Duration of action for oral dosing is typically around 8–12 hours (effects from IV boluses are shorter and an infusion is used for sustained control while monitoring).
  • Avoid or limit alcohol while taking trandate — alcohol can increase drowsiness and dizziness and worsen low blood pressure.
  • The most common side effect is dizziness (also common are tiredness/fatigue, drowsiness and nausea).
  • Would you like to try trandate without a prescription?

Basic Trandate Information

  • INN (International Nonproprietary Name): Labetalol
  • Brand Names Available In Australia: Trandate, Presolol (tablets typically 100 mg and 200 mg in bottle or blister packaging)
  • ATC Code: C07AG01
  • Forms & Dosages: Tablets 100 mg, 200 mg, 300 mg (400 mg in some regions); Solution for injection 5 mg/mL and 100 mg/20 mL vials (IV)
  • Manufacturers In Australia: GSK (UK listed regionally), Amdipharm, Sandoz, Mylan, Apotex and other generics (local supplier varies)
  • Registration Status In Australia: not specified
  • OTC / Rx Classification: Prescription-only (Rx) in reviewed markets

Critical Warnings, Patient Protection And Safety (Australia)

High-Risk Groups (Elderly, Pregnancy, Chronic Illness)

Patients often want to know who should be extra careful with trandate.

Labetalol can cause severe hypotension, marked bradycardia and bronchospasm, so safety comes first.

Patients must consult their GP or a specialist before starting Trandate or Presolol and must tell clinicians if pregnant, breastfeeding, elderly, diabetic, asthmatic or living with heart or liver disease.

Absolute contraindications include bronchial asthma, overt cardiac failure, cardiogenic shock, second or third-degree heart block (without a pacemaker), severe bradycardia and hypersensitivity to labetalol.

Liver impairment requires close monitoring and may need dose reduction.

For preeclampsia, labetalol should only be used under specialist care and hospital guidelines.

Advise patients to have emergency contacts and an action plan for severe dizziness, fainting or breathing difficulty.

  • Immediate red flags to report to clinician: severe shortness of breath or wheeze; fainting or collapse; chest pain; severe light-headedness; jaundice or dark urine.

Before you start checklist:

  • Are you pregnant or breastfeeding?
  • Do you have asthma or chronic obstructive airway disease?
  • Do you have known heart block or a pacemaker?
  • Are you taking other blood pressure medicines, insulin or medicines for diabetes?
  • Do you have liver disease or unexplained raised liver tests?
  • Document allergies and current prescription medicines in e-prescriptions or telehealth notes.

Refer to TGA guidance and seek pharmacist counselling for PBS authority or subsidy queries.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Many patients ask whether they can drive after starting trandate.

Labetalol commonly causes drowsiness, dizziness and postural hypotension, which affect driving and safety-critical work.

Under Australian road rules and workplace health and safety, individuals must not drive or operate hazardous equipment until they know how the drug affects them.

Trial first doses at home and avoid alcohol while adjusting to the medicine.

  • Can I drive/return to work? checklist:
  • Have you taken a new dose or changed dose today?
  • Do you feel dizzy, drowsy or light-headed within two hours of the dose?
  • Is your job safety-critical (driving, heavy machinery, construction)? If yes, inform your employer or occupational health clinician.
  • Obtain medical clearance if required by employer policy.
Situation Recommended Waiting Period
Starting treatment or dose increase Try first dose at home; avoid driving for 24–48 hours until effects known
Stable on unchanged dose No routine restriction; assess individual tolerance
Experienced dizziness or fainting Do not drive until symptoms resolved and clinician confirms safety

Pharmacist suggested wording for medical certificates: “Patient commenced on labetalol; avoid driving or safety-critical duties until tolerance established; reassessment date: [dd/mm/yyyy].”

Advise patients to check state transport authority guidance and Safe Work Australia for workplace assessments.

Q&A — “Can I Drive After Taking It In Australia?”

Q: Can I drive after taking labetalol?

A: Not until you know how it affects you; if you feel dizzy, drowsy or light-headed, do not drive and inform your GP if your job involves driving.

Usage Basics

INN, Brand Names Available In Australia

People searching for “trandate” want clear brand and dosing information.

INN: labetalol.

ATC code: C07AG01, a non-selective beta-blocker with alpha-blocking activity.

Australian brands: Trandate and Presolol, typically supplied as 100 mg and 200 mg tablets in bottles or blister packs.

IV formulations such as 5 mg/mL are used in hospitals for hypertensive emergencies.

  • INN: Labetalol
  • ATC Code: C07AG01
  • Brand Names: Trandate, Presolol
  • Dosage Forms: 100 mg and 200 mg tablets; IV solution 5 mg/mL and 100 mg/20 mL vials
  • Check packaging for manufacturer (GSK, Sandoz, Mylan, Amdipharm) and expiry date, and verify PBS listing for subsidy eligibility.

    Legal Classification (TGA-Approved, PBS-Listed)

    Labetalol is prescription-only (Rx) across reviewed markets.

    In Australia, confirm TGA registration and current PBS status before advising about cost or subsidy.

    PBS rules change and some uses may require authority or specialist initiation.

    • Steps to check TGA/PBS status: consult the TGA ARTG database, check the PBS Schedule and confirm Product Information.
    • Use e-prescriptions and telehealth scripts where accepted.
    • Document indication when prescribing under PBS rules.
    Medicine Name TGA ARTG Number PBS Status Typical Authority Requirement
    Labetalol (Trandate/Presolol) not specified Check PBS listings May require specialist initiation for some indications

    Rural patients can use community pharmacies or accredited online pharmacies for dispensing.

    Dosing Guide (Practical Australian Focus)

    Standard Regimens (PBS Reference Dosing)

    Patients often want a clear starting dose and what to expect when titrating.

    Oral hypertension typical initiation is 100 mg twice daily, with maintenance commonly 200–400 mg twice daily and maximum up to 2,400 mg/day divided.

    Hypertensive emergency IV regimen begins with a 20 mg slow IV bolus over two minutes, repeat or escalate to 40–80 mg every 10 minutes as needed, or start an infusion 0.5–2 mg/min titrated to effect.

    Elderly patients should start lower and titrate cautiously due to orthostatic hypotension risk.

    Renal impairment usually requires no adjustment but monitor for enhanced effects.

    Liver impairment may need dose reduction and LFT monitoring.

    • Titration steps checklist: start low, review BP/HR within 1–2 weeks, increase slowly, watch for dizziness or bradycardia, document BP targets and communicate changes to GP.
    Route Typical Dosing Monitoring
    Oral 100 mg twice daily → 200–400 mg twice daily maintenance BP, HR, symptoms of hypotension
    IV (Hospital) 20 mg slow bolus, repeat or infusion 0.5–2 mg/min Continuous BP monitoring, cardiac monitoring

    Coordinate any dose changes with the GP and document BP targets clearly.

    Q&A — “What If I Miss A Dose?”

    Q: What if I miss a dose of Trandate?

    A: Take it as soon as you remember unless it is close to the next dose; skip the missed dose rather than doubling up and contact your pharmacist if unsure.

    Interaction Chart (Food, Drink And Medicines)

    Food And Drinks (Alcohol, Coffee, Australian Diet Context)

    Patients commonly ask about alcohol and coffee when starting blood pressure medication.

    Alcohol increases the sedative and hypotensive effects of labetalol, so minimise intake during initiation or dose changes.

    Caffeine may transiently blunt antihypertensive effect; keep coffee intake consistent rather than stopping or starting suddenly.

    Salt intake influences blood pressure control—follow Australian dietary guidance to reduce processed salt and prioritise fresh foods.

    Grapefruit is not a major interaction with labetalol but check other medicines for interactions.

    Substance Effect Action
    Alcohol Increases drowsiness and hypotension Avoid or minimise, especially during initiation
    Caffeine (Coffee) May transiently affect BP response Maintain consistent intake
    Salt High intake worsens BP control Reduce processed foods and added salt
    • Dietary counselling tips: choose fresh produce, swap processed snacks for whole foods, read labels for sodium, and discuss a salt-reduced plan with a dietitian if necessary.

    Common Drug Conflicts

    Common medication interactions are a frequent pharmacy question.

    Other antihypertensives (ACE inhibitors, calcium channel blockers) can add hypotensive effects so monitor blood pressure.

    Beta-agonists such as salbutamol may have reduced effect or paradoxical reactions when given with non-selective beta-blockers like labetalol.

    CYP interactions with labetalol are limited but check for medicines affecting hepatic clearance.

    Warfarin and other anticoagulants require monitoring if clinical status changes.

    NSAIDs can reduce antihypertensive efficacy.

    In diabetes, beta-blockers can mask hypoglycaemia symptoms such as tachycardia, so adjust monitoring accordingly.

    • High-priority interactions to flag in pharmacy software: asthma medicines, insulin/oral hypoglycaemics, other BP agents, NSAIDs, warfarin.

    Always perform medicines reconciliation during telehealth and advise patients to check with a pharmacist before starting OTC medicines.

    User Reports & Trends (Australian Patient Feedback)

    What do Australians say about Trandate on forums and review sites?

    Common patient-reported effects include initial dizziness, fatigue and reduced exercise tolerance, especially when dose is increased.

    Many report effective blood pressure lowering at 200–400 mg twice daily.

    Some patients describe flushing, scalp tingling and skin warmth early in therapy.

    Cost and brand choice are frequent concerns, with many patients asking about generics versus Trandate and PBS subsidy availability.

    Rural patients often describe longer waits for specialist review and occasional IV availability delays in smaller hospitals.

    • Top reported pros: effective BP control, IV option for emergencies, used in pregnancy under specialist care.
    • Top reported cons: dizziness, fatigue, cost sensitivity, liver monitoring concerns.
    Reported Issue Typical Onset
    Dizziness/faintness Within days of starting or dose increase
    Fatigue First 1–2 weeks
    Effective BP lowering Within days to weeks depending on dose

    Note that these are individual reports and anecdotal; discuss evidence and monitoring with the prescriber.

    Access & Purchase Options (Australia)

    National Chains And Community Pharmacies

    Trandate and labetalol are prescription-only and dispensed by major Australian pharmacy chains and independent pharmacies.

    Availability and price vary between Chemist Warehouse, Priceline, TerryWhite Chemmart and local independents.

    Pharmacists can supply generics where appropriate and provide counselling on dosing, side effects and storage.

    Pharmacy Typical Services Pros / Cons
    Chemist Warehouse High stock, competitive prices Good for low price; variable counselling time
    TerryWhite Chemmart Clinical counselling, vaccination and home medicines reviews Stronger clinical support; price may be higher
    Independent Pharmacy Personalised service, local knowledge Good continuity of care; stock may vary
    • What to bring to the pharmacy: current prescription, Medicare card or concession card, allergy list and current medication list.

    In our online pharmacy, trandate is available without a prescription, with discreet delivery to Australia in 9-21 days.

    Online Pharmacies And Telehealth E-Prescriptions

    Telehealth consultations and e-prescriptions are accepted in Australia for ongoing hypertension care, but prescribers must be aware of PBS authority rules.

    Accredited online pharmacies can dispatch to metropolitan and many rural areas, but confirm delivery times for remote areas.

    • Steps to obtain medication online: GP consult → e-script → accredited pharmacy accepts script → delivery to address.

    Rural patients should confirm local hospital IV access if emergency care is needed and maintain an emergency plan with their local health service.

    Mechanism Of Action & Pharmacology (Simple + Clinical)

    Simplified Explanation

    Patients want plain explanations of how trandate works.

    Labetalol is a non-selective beta-blocker with additional alpha-adrenergic blocking activity (ATC C07AG01).

    Beta blockade reduces heart rate and contractility, lowering cardiac output.

    Alpha blockade reduces peripheral vascular resistance, causing vasodilation.

    Combined action reduces blood pressure clinically.

  • Beta-blocker: lowers heart rate and cardiac output.
  • Alpha-blocker: dilates blood vessels to reduce vascular resistance.
  • Oral onset is over hours to days, while IV bolus produces rapid BP reduction for emergencies.

    Hepatic metabolism predominates, so caution is required in liver impairment.

    Clinical Pharmacokinetics (Concise)

    Oral labetalol is well absorbed but bioavailability varies due to first-pass metabolism.

    IV formulations provide rapid predictable onset for acute care.

    Hepatic metabolism is the main route, so monitor liver function for prolonged therapy or known liver disease.

    Half-life supports twice-daily dosing for many patients, though titration can change frequency.

    In overdose expect severe hypotension, bradycardia and bronchospasm; manage supportively with IV fluids, atropine, glucagon and vasopressors as needed.

    Form Onset Dosing Frequency Monitoring Needs
    Oral tablets Hours to days Usually twice daily BP, HR, LFTs if indicated
    IV solution Minutes As per bolus/infusion protocol Continuous BP and cardiac monitoring
    • Monitoring checklist: blood pressure, heart rate, LFTs for prolonged therapy, assess for bronchospasm in patients with respiratory disease.

    Indications & Off-Label Uses In Australia

    TGA-Approved Indications

    Primary indication for oral labetalol is chronic hypertension.

    IV labetalol is used for hypertensive emergencies in hospital settings.

    TGA lists labetalol as a prescription antihypertensive; check ARTG/Product Information for specific formulations.

    In pregnancy, labetalol is frequently used for severe hypertension and preeclampsia under specialist care and hospital protocols.

    Form Primary Indication
    Oral Chronic hypertension
    IV Hypertensive emergency
    • Always reference current TGA and hospital obstetric guidelines for pregnancy use.

    Off-Label Uses And Specialist Practice

    Off-label uses reported in practice include perioperative BP control, some arrhythmias and specialist-led pediatric hypertensive crises.

    Pheochromocytoma typically requires alpha blockade first, so labetalol alone is relatively contraindicated.

    Any off-label use must be documented, consented and managed by a specialist with clear monitoring.

    • Checklist for consenting to off-label use: explain rationale, document expected benefits and risks, obtain written or recorded consent, plan monitoring and follow-up.

    Local hospital formularies and state health directives should guide protocols and retrieval pathways for rural hospitals.

    Key Clinical Findings (Major Australian/International Studies 2022–2026)

    Clinicians ask whether recent evidence changes practice for labetalol.

    Labetalol remains supported for acute blood pressure lowering (IV) and as a chronic agent where beta-blockade is suitable.

    Comparative trials continue to evaluate maternal outcomes for labetalol versus hydralazine and other agents in preeclampsia, and many guidelines still endorse labetalol as a first-line option in specific settings.

    Recent meta-analyses from 2022–2026 reinforce monitoring for hepatic events and caution in asthma and obstructive airway disease.

    Australian studies focus on implementing protocols in regional hospitals and telemedicine-supported BP management.

    • Study takeaways: effective for acute and chronic BP control; pregnancy data supportive with specialist oversight; monitor liver function and respiratory history.
    Study Year Population Key Outcome
    Meta-analyses (various) 2022–2026 Pregnant and general hypertensive populations Support for labetalol in many obstetric protocols; need for monitoring

    Alternatives Matrix (PBS-Listed Comparators)

    PBS-Listed Alternatives Comparison Table

    Drug Class Typical Starting Dose PBS Subsidy Pros Cons
    Labetalol (Trandate) Non-selective beta-blocker with alpha-block 100 mg twice daily Check PBS Alpha activity; IV option; used in pregnancy under specialist care Bronchospasm risk; hepatic monitoring; may mask hypoglycaemia
    Metoprolol Beta-1 selective blocker 25–50 mg daily PBS-listed Less bronchospasm risk vs non-selective May still mask hypoglycaemia; limited pregnancy data
    Amlodipine Calcium channel blocker 5 mg daily PBS-listed Good for isolated systolic hypertension; no beta effects Peripheral oedema; not ideal in some cardiac conditions
    Enalapril ACE inhibitor 5 mg daily PBS-listed Strong evidence for heart failure and diabetes Contraindicated in pregnancy
    • Consider pregnancy, asthma and heart failure when choosing an alternative; ACE inhibitors are not suitable in pregnancy.

    Pros And Cons Checklist

    • Advantages: effective BP reduction, IV option for emergencies, can be used in pregnancy with specialist oversight.
    • Disadvantages: risk of bronchospasm, potential hepatotoxicity requiring monitoring, may mask hypoglycaemia symptoms.
    • Patient factors: asthma, peripheral vascular disease and diabetes guide shared decision-making.

    Common Questions From Australian Pharmacy Consultations (FAQ Aggregate)

    Pharmacists routinely answer the same practical questions about trandate.

    Is Trandate safe in pregnancy? It is used for severe hypertension under specialist care, with risk/benefit discussion and monitoring.

    Will it make me tired? Fatigue and dizziness are common, especially during the first 1–2 weeks or after dose increases.

    Can I stop suddenly? Do not stop abruptly; taper under clinician guidance to avoid rebound hypertension.

    How much does it cost? Check PBS listing and pharmacy prices; cost varies by brand and subsidy status.

    Do I need regular blood tests? Monitor BP and HR regularly; LFTs if clinically indicated or prolonged therapy.

    • Top 10 pharmacist counselling points: confirm indication and dose, review contraindications, check concurrent meds, discuss side effects, advise on driving/work safety, explain missed-dose instructions, document counselling, arrange follow-up, discuss PBS authority if needed, provide written advice.

    Follow-up checklist: review at 1–2 weeks after initiation then monthly until stable or as clinician recommends.

    Price & Access Comparison (Pharmacy/Source Table)

    Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required

    Source Typical Price Range (Non-PBS) PBS Subsidy Prescription Required
    Community Pharmacy $10–$40 typical for a dispensed pack (varies) Yes, check PBS and authority Yes
    National Chain (e.g. Chemist Warehouse) $8–$30 depending on generic Yes, check PBS Yes
    Online Accredited Pharmacy $10–$35 plus delivery Yes, check PBS Yes (e-script accepted)
    • How to reduce cost: ask GP for PBS authority if eligible, request a generic, compare pharmacies and present concession card.

    Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

    • Check PBS subsidy status before ordering.
    • Ask the pharmacist about current stock and expected substitution (generic vs brand).
    • Confirm delivery times for online orders and allow extra time for rural addresses.
    • For rural areas confirm local hospital IV access and emergency pathways.
    • Keep an up-to-date medication list for telehealth consultations.

    Registration & Regulation (TGA And PBS Specifics)

    TGA Approval

    Labetalol is a prescription medicine registered in multiple jurisdictions.

    Australian prescribers should verify the current TGA ARTG entry and product formulation before prescribing.

    Hospital IV products and oral tablets may have separate ARTG entries and Product Information leaflets.

    • Regulatory checks: confirm ARTG entry, review Product Information (PI), consult PBS schedule for subsidy details.
  • ARTG: Australian Register of Therapeutic Goods entry for registered products.
  • PBS: Pharmaceutical Benefits Scheme listing and subsidy information.
  • PBS Subsidy Details

    PBS listing can vary by formulation and indication and some uses may require authority prescriptions such as specialist initiation in pregnancy.

    Costs differ for general and concession patients and change over time.

    Prescribers should use ePBS tools when writing scripts and patients should present concession cards where relevant.

    Patient Category Co-payment
    General Varies; check current PBS co-payment
    Concession Lower co-payment; present concession card
    • Authority application steps: confirm indication, complete authority form or e-authority, document specialist initiation if required.

    Storage & Handling (Australian Climate And Pharmacies)

    Household Storage In Australian Climate (Heat/Humidity)

    Proper storage is important in hot, humid parts of Australia.

    Store tablets at 20°–25°C with allowed excursions 15°–30°C.

    Protect tablets from moisture and light; keep in original container and away from bathrooms.

    Do not leave medication in a hot car glovebox or exposed to extreme heat or freezing.

    Recommended Temperature Action If Exposed
    20°–25°C (acceptable 15°–30°C) Store in original container; discard if exposed to extremes
    • Home storage checklist: keep in a cool, dry place, label doses if using blister packs, keep out of reach of children.

    Cold-Chain Handling For Pharmacies

    IV solutions must not be frozen and should follow supplier storage specifications.

    Pharmacies should store stock in temperature-monitored areas and check expiry dates routinely.

    • Pharmacy SOP checklist: maintain temperature logs, verify supplier cold-chain handling, rotate stock and have an emergency backup plan for power outages.

    Guidelines For Proper Use And Pharmacist Counselling Style

    Australian Pharmacist Counselling Checklist

    Patients appreciate clear, concise counselling on starting a new BP tablet.

    Confirm indication and prescribed dose and review contraindications such as asthma and heart block.

    Check concurrent medicines, pregnancy status and allergies.

    Discuss common side effects like dizziness, fatigue, scalp tingling and signs of liver injury.

    Advise on driving and workplace safety and explain missed-dose instructions and emergency signs warranting urgent care.

    Document counselling in the patient record and liaise with the GP for dosing or adverse effects.

    • Consult checklist: current med list, allergies, pregnancy status, BP targets, agreed follow-up plan and referral if specialist oversight needed.

    Use plain language and culturally appropriate communication for Aboriginal and Torres Strait Islander patients and people from CALD communities.

    Suggested scripted counselling: “This medicine, called labetalol or Trandate, lowers blood pressure by slowing the heart and relaxing blood vessels. Start at the dose your GP prescribed, watch for dizziness and breathlessness, avoid driving until you know how it affects you, and come back for review in 1–2 weeks or earlier if problems occur.”

    Refer to PBS and TGA Product Information for detailed prescribing and safety guidance.

    Delivery Across Australia

    City Region Delivery Time
    Sydney New South Wales 9-14 days
    Melbourne Victoria 9-14 days
    Brisbane Queensland 9-14 days
    Perth Western Australia 9-14 days
    Adelaide South Australia 9-14 days
    Canberra Australian Capital Territory 9-14 days
    Hobart Tasmania 9-14 days
    Darwin Northern Territory 9-14 days
    Gold Coast Queensland 9-14 days
    Newcastle New South Wales 9-14 days
    Wollongong New South Wales 14-21 days
    Geelong Victoria 14-21 days
    Townsville Queensland 14-21 days
    Cairns Queensland 14-21 days

    Related products